Implications of <scp>RAS</scp> mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypesDaniel Rivera, Tapan M. Kadia, Musa Yılmaz et al.|American Journal of Hematology|2022Cited by 33
Outcomes of Patients With Newly Diagnosed AML and HyperleukocytosisFadi Haddad, Tapan M. Kadia, Koji Sasaki et al.|JCO Oncology Practice|2024Cited by 11
Contemporary outcomes for adults with AML requiring ICU admission.Danielle Hammond, Tapan M. Kadia, Koji Sasaki et al.|Journal of Clinical Oncology|2021Cited by 4
Outcomes of patients with newly diagnosed acute myeloid leukemia (AML) and hyperleukocytosis.Fadi Haddad, Tapan M. Kadia, Koji Sasaki et al.|Journal of Clinical Oncology|2022Cited by 0